The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15287
StudyName: Eligibility Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer NCT02333370
Date of export from the portal: 02.07.2020
Date of Upload / last change: 25.05.2016
License: Creative Commons BY 4.0

----

Description: 
Phase Ib Dose-escalation, Phase II Study of LEE011 and Letrozole for Treatment of Postmenopausal Women With Hormone Receptor Positive, HER2-negative, Advanced Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT02333370
